[Comment] The imperative for increased investment for an HIV cure

The transformation of HIV from a fatal disease to a manageable condition represents one of medicine's greatest achievements. However, without a cure, HIV remains an urgent global health challenge. Despite widespread availability of prevention tools and treatments in high-income countries, globally, in 2024, 40·8 million people were living with HIV, 1·3 million people newly acquired HIV, and 630 000 people died from AIDS-related illnesses.1 These numbers represent people facing daily psychological, social, and physical burdens associated with lifelong therapy, persistent stigma, economic hardship, and uncertain access to care.